Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ELISPOT assay: a personal retrospective.

Jonathon D Sedgwick1

  • 1Stress and Immune Responses, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.

Methods in Molecular Biology (Clifton, N.J.)
|June 7, 2005
PubMed
Summary

The enzyme-linked immunospot (ELISPOT) assay was developed in Perth, Western Australia, in 1981-1982. This recollection details the early development, challenges, and amusing naming insights of the ELISPOT technique.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responses.

Oncoimmunology·2022
Same author

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.

JCO precision oncology·2021
Same author

The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling.

Frontiers in immunology·2018
Same author

Loss of TNF signaling facilitates the development of a novel Ly-6C(low) macrophage population permissive for Leishmania major infection.

Journal of immunology (Baltimore, Md. : 1950)·2012
Same author

A critical function for CD200 in lung immune homeostasis and the severity of influenza infection.

Nature immunology·2008
Same author

STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

The Journal of clinical investigation·2008

Area of Science:

  • Immunology
  • Biotechnology

Background:

  • The enzyme-linked immunospot (ELISPOT) assay was first described in 1983 by two independent research groups.
  • This paper details the development of the ELISPOT technique by the Perth, Western Australia-based group.

Discussion:

  • Recounts the early studies from 1981-1982 that led to the assay's successful development.
  • Highlights both the setbacks encountered and the solutions devised during the assay's early stages.
  • Provides lesser-known, amusing anecdotes regarding the naming of the ELISPOT assay by the Gothenburg group.

Key Insights:

  • The ELISPOT assay's development involved overcoming specific scientific challenges through innovative problem-solving.
  • The collaborative yet independent nature of scientific discovery is exemplified by the parallel development in Perth and Gothenburg.
  • Personal recollections offer unique historical context to a widely used immunological technique.

Outlook:

  • Understanding the historical development of assays like ELISPOT can inform future technological advancements.
  • The insights into early challenges and solutions may guide researchers working on novel immunoassay development.
  • Preserving the history and context of scientific techniques is crucial for the scientific community.

Related Experiment Videos